Stock data
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT) reported revenue of US$1.12M and net income of -US$11.17M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.12M | US$0.80M | -US$12.51M | -US$11.17M | — |
| 2024 | US$0.04M | US$0.04M | -US$10.97M | -US$8.81M | — |
| 2023 | — | — | -US$11.40M | -US$10.23M | — |
| 2022 | — | — | -US$9.95M | -US$9.89M | — |
| 2021 | — | — | -US$5.67M | -US$6.32M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.91M | -US$2.91M | — |
| 2026-03-31 | US$0.56M | -US$3.52M | — |
| 2025-12-31 | US$0.24M | -US$2.94M | — |
| 2025-09-30 | US$0.27M | -US$2.91M | — |
| 2025-06-30 | US$0.42M | -US$2.90M | — |
| 2025-03-31 | US$0.20M | -US$2.42M | — |
| 2024-12-31 | — | -US$2.88M | — |
| 2024-09-30 | — | -US$2.47M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.